Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate Yahoo Finance Nawigacja wpisu Startup Corsera Health aims to bring preventive heart medicine to the masses – BioPharma Dive Newcastle University receives £22m for medicine research – Yahoo Finance